Center for Scientific Review; Notice of Closed Meetings
Published Date: 11/26/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on January 27-28, 2026, to review grant applications about sensory technologies like vision and hearing. These meetings are private to protect secret business info and personal details. This affects small businesses applying for grants and helps keep their ideas safe while deciding who gets funding.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Confidential Grant Reviews Protect Small Firms
The NIH review panel will hold a closed virtual meeting on January 27-28, 2026 to review grant applications for sensory technologies. The meetings are closed under 5 U.S.C. 552b(c)(4) and (c)(6) because discussions could disclose confidential trade secrets, patentable material, commercial property, and personal information, which protects small businesses’ ideas during funding decisions.
Public Excluded From Grant Review Meetings
The Center for Scientific Review’s meeting on January 27-28, 2026 (9:30 a.m. to 1:00 p.m., virtual) is closed to the public. Because the meeting is closed under the cited sections of law, members of the public cannot observe the review and evaluation of these grant applications.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2025-21278 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 22-23, 2026, to review important grant applications about brain research. These meetings are private to protect secret ideas and personal info. Scientists applying for grants and NIH staff are the main players, with no new costs or changes announced.
Next: 2025-21280 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding a closed virtual meeting on January 21-22, 2026, to review grant applications related to motor function, speech, and rehabilitation. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants should note this schedule, but no new changes or funding impacts are announced.